A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Active, not recruiting · NCT06544616 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 2 | 2026-09-25 | NCT06544616 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Pharmaceutica N.V., Belgium | 13 |
90 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.